October price plunge is a signal to buy, as analyst and institutional trends suggest they, too, will be buying the stock.

What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, ...

Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...

Abbott Laboratories (ABT) stock has drifted slightly lower this month, with shares showing a 7% drop over the past month.

9 analysts have shared their evaluations of Abbott Laboratories (NYSE:ABT) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 5.57%, ...

The company's stock traded at approximately $49.14 per share 10 years ago. If you had invested $10,000, you could have bought roughly 204 shares. Currently, shares trade at $134.92, meaning your ...

Abbott Laboratories (NYSE:ABT) will release its first-quarter earnings results before the opening bell on Wednesday, April 16. Analysts expect the company to report quarterly earnings at $1.07 per ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...